PM

Paul McKenzie

CSL Limited | Chief Operating Officer, Executive Director, Chief Executive Officer, Managing Director
Dr McKenzie has than 30 years of leadership experience in the global biotechnology industry, including managing complex organisations through compelling growth and transformation. Since joining CSL as COO in 2019, Prior to joining CSL, Dr McKenzie was Executive Vice President of Pharmaceutical Operations & Technology at Biogen. He also served in a range of progressively senior level roles in R&D and manufacturing at Johnson & Johnson, Bristol-Myers Squibb and Merck.

Company and Roles

Company
Title
Tenure
Since
CSL
CSL Limited
  • Chief Operating Officer
  • Executive Director
  • Chief Executive Officer
  • Managing Director
1yrs, 5mthDec 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
CSL
CSL Limited
01/09/23N/A22,456N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
CSL
CSL Limited
12/10/23
Issued
44,095$238.240$10,505,192Issue of securities
CSL
CSL Limited
01/09/23
Exercise
3,120$269.090$839,560Conversion of securities
CSL
CSL Limited
01/09/23
Expiry
5,384$269.090$1,448,780As advised by the company
CSL
CSL Limited
01/09/23
Sell
1,361$268.599$365,563On-market trade
CSL
CSL Limited
01/09/23
Buy
3,120$269.090$839,560Conversion of securities